Largest Swedish (OMX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED May 10, 2025

Discover large cap Swedish Pharmaceuticals & Biotech companies that are on the OMX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

106 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
SOBI
Swedish Orphan Biovitrum
SEK 299.800%4.1%SEK 103.0bSEK 352.42PE26xE16.7%n/a
CAMX
Camurus
SEK 667.505.6%18.4%SEK 39.1bSEK 737.29PE91.4xE45.9%n/a
ALIF B
AddLife
SEK 188.30-0.4%74.0%SEK 22.9bSEK 184.00PE74.3xE28.9%0.4%
VITR
Vitrolife
SEK 158.202.3%-11.3%SEK 21.4bSEK 242.40PE43xE18.6%0.7%
BONEX
Bonesupport Holding
SEK 288.80-6.8%25.0%SEK 19.0bSEK 434.67PE155.5xE56.1%n/a
BIOA B
BioArctic
SEK 178.20-9.2%-12.2%SEK 15.8bSEK 302.40PS61.3xE47.3%0%
BIOT
Biotage
SEK 141.700.4%-16.6%SEK 11.3bSEK 143.00PE44.5xE20.7%1.2%
BIOG B
BioGaia
SEK 100.90-4.3%-19.2%SEK 10.2bSEK 150.00PE33xE19.9%6.8%
MCAP
MedCap
SEK 447.500.2%-10.9%SEK 6.7bSEK 527.00PE33.2xS13.1%n/a
SECARE
Swedencare
SEK 41.005.5%-24.8%SEK 6.6bSEK 54.33PE70.7xE41.6%0.6%
FLERIE
Flerie
SEK 42.955.6%n/aSEK 3.4bSEK 50.50PS8382.4xn/an/a
CRNO B
Cereno Scientific
SEK 8.9210.3%128.7%SEK 2.5bn/aPS31xS-150.1%n/a
BICO
BICO Group
SEK 33.94-1.2%-22.5%SEK 2.4bSEK 66.00PS1.3xE75.2%n/a
BINV
BioInvent International
SEK 32.60-2.0%29.9%SEK 2.1bSEK 90.00PS35.3xE81.8%n/a
DVYSR
Devyser Diagnostics
SEK 113.408.4%13.6%SEK 1.9bSEK 160.85PS8.5xE110.0%n/a
VICO
Vicore Pharma Holding
SEK 7.94-5.9%-61.2%SEK 1.9bSEK 31.52PS310.7xE36.5%n/a
HNSA
Hansa Biopharma
SEK 25.94-12.3%-18.8%SEK 1.8bSEK 95.00PS9.7xE60.7%n/a
GENO
Genovis AB (publ.)
SEK 22.85-6.2%-24.1%SEK 1.5bSEK 37.67PE45.4xE15.5%n/a
EGTX
Egetis Therapeutics
SEK 3.67-3.4%-41.5%SEK 1.3bSEK 12.00PS28.2xE69.0%n/a
DMYD B
Diamyd Medical
SEK 9.14-9.5%-16.0%SEK 1.3bn/aPS6895.2xE-7.3%n/a
XSPRAY
Xspray Pharma
SEK 32.10-5.6%-24.8%SEK 1.2bSEK 55.50PS666.7xE123.5%n/a
SANION
Saniona
SEK 8.00-3.0%344.9%SEK 1.1bSEK 12.00PE5.8xS11.6%n/a
SYNACT
SynAct Pharma
SEK 18.82-18.7%164.5%SEK 922.3mSEK 22.00PB4.3xE59.9%n/a
IBT B
Infant Bacterial Therapeutics
SEK 60.605.4%-34.8%SEK 816.4mn/aPB5.3xn/an/a
Page 1 of 5